Excess Respiratory Hospitalisations Associated with Influenza, Respiratory Syncytial Virus and SARS‐CoV‐2 in Singapore from 2015 to 2023

Documenti analoghi

• Aetiological Fraction of Influenza, Respiratory Syncytial Virus and Other Respiratory Pathogens in Infants Aged < 1 Year Hospitalised With Respiratory and Non‐Respiratory Medical Illness in South Africa, 2016–2018
  di: Nicole Wolter, et al.
  Pubblicazione: (2025)
• Changes in Respiratory Syncytial Virus‐Associated Hospitalisations Epidemiology After Nirsevimab Introduction in Lyon, France
  di: Cécile Chauvel, et al.
  Pubblicazione: (2024)
• Diagnostic Performance of Self‐Collected Respiratory Swabs for SARS‐CoV‐2 and Influenza Virus in Community‐Dwelling Older Adults
  di: Xinyi Li, et al.
  Pubblicazione: (2026)
• Assessment of Illness Severity in Adults Hospitalized With Acute Respiratory Tract Infection due to Influenza, Respiratory Syncytial Virus, or Human Metapneumovirus
  di: Ann R. Falsey, et al.
  Pubblicazione: (2024)
• Comparison of the Burden and Temporal Pattern of Hospitalisations Associated With Respiratory Syncytial Virus (RSV) Before and After COVID‐19 in New Zealand
  di: Nikki Turner, et al.
  Pubblicazione: (2024)